Jarrod Longcor

Company: Cellectar Biosciences Inc.

Job title: Chief Operating Officer

Seminars:

Panel Discussion: Addressing Barriers in Supply Chains to Ensure Reliable Isotope Access & Consistent Patient Delivery 9:30 am

Identify sourcing and logistics bottlenecks including cold chain constraints, regulatory delays, and cross-border customs challenges that impact isotope availability and the timely delivery of radiopharmaceuticals. Compare centralized and local production models for short- and long-lived isotopes to minimize supply chain risks, costs, and lead times while ensuring the delivery of therapies to clinical sites on…Read more

day: Conference Day One

Roundtable Discussion: Addressing Facility Downtime & Regulatory Delays by Designing Robust Infrastructure Strategy to Accelerate Safe, Scalable Radiopharmaceutical Manufacturing 12:00 pm

Compare the cost, speed, and scalability trade-offs between building new facilities and repurposing existing infrastructure for radiopharmaceutical production. Explore how isotope-specific properties (e.g. half-life, emission type, regulatory perception) impact facility design, contamination protocols, and downtime risk. Understand how evolving regulatory expectations and environmental monitoring requirements influence long-term compliance, capacity, and facility utilization.Read more

day: Conference Day One

Impact of Isotope Half-life: Long-vs. Short-Lived Radiotherapeutics and Differences in Manufacturing, Quality & Distribution to Clinic 1:30 pm

Impact of short vs long half-life isotopes on the manufacturing process and logistics to finished product Explore how established distribution models for isotopes like Lutetium-177 differ from those required for short half-life radiotherapies (Astatine-211), and what adaptations are needed. Discuss what elements of licensing, training, automation, packaging can be reused with both isotope types, and…Read more

day: Conference Day One